title: Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.
abstract: Electrophoretic karyotype (EK) was used to type 13 clinical isolates of Cryptococcus neoformans from eight AIDS patients. All of the isolates were also tested for their in vitro susceptibilities to fluconazole, itraconazole, D0870, flucytosine, and amphotericin B by a broth macrodilution technique performed according to the National Committee for Clinical Laboratory Standards recommendations. Although all strains were isolated from a limited geographic area, DNA typing showed a wide genetic variation in this group of patients, yielding seven different patterns. Two patients in whom C. neoformans was isolated in the same time period shared similar EK profiles, suggesting the possibility of cross-infection. In three patients, sequential isolates were evaluated: in two of them, EK analysis showed the persistence of the same genotype throughout the infection, whereas from the third, two isolates of C. neoformans with two different DNA profiles were obtained. Despite the small number of strains considered in this study, our susceptibility data indicate that C. neoformans isolates are very susceptible to the new triazoles.
authors.affiliation: Fungus Testing Laboratory, Department of Pathology, University of Texas Health Science Center, San Antonio 78284-7750, USA.
authors.forename: F
authors.initials: F
authors.lastname: Barchiesi
authors.forename: R J
authors.initials: RJ
authors.lastname: Hollis
authors.forename: S A
authors.initials: SA
authors.lastname: Messer
authors.forename: G
authors.initials: G
authors.lastname: Scalise
authors.forename: M G
authors.initials: MG
authors.lastname: Rinaldi
authors.forename: M A
authors.initials: MA
authors.lastname: Pfaller
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000935:Antifungal Agents / Q000494:pharmacology*; D001431:Bacteriological Techniques; D003453:Cryptococcosis / Q000150:complications* / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000187:drug effects*; D004587:Electrophoresis, Agar Gel; D006801:Humans; D007621:Karyotyping; D008826:Microbial Sensitivity Tests
chemical_list: D000935:Antifungal Agents